← Open Payments lookup

LARA SHIGIHARA: Open Payments

NPI 1427660992 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,690 in 84 payments from 15 companies in 2025. Trend: 2023 $1,489 · 2024 $1,897 · 2025 $1,690

Food & beverage: $1,680Education: $10
CompanyPaymentsAmount
ABBVIE INC.23$425
AstraZeneca Pharmaceuticals LP14$306
Amgen Inc.8$178
PFIZER INC.9$163
Novo Nordisk Inc7$147
GlaxoSmithKline, LLC.5$114
Otsuka America Pharmaceutical, Inc.4$92
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$56
Boehringer Ingelheim Pharmaceuticals, Inc.3$47
Lilly USA, LLC2$43

Products named: VRAYLAR, BREZTRI, NURTEC ODT, OTEZLA, FARXIGA, REXULTI, Wegovy, SHINGRIX.

Industry payments across NV — which companies pay providers there.